FEDERALUnknownHealthcareHealthcareLow
Elite Pharmaceuticals
bd_48aac93b7a615dd3 · schema v1 · pii pii-v1
Full breach record for Elite Pharmaceuticals →Elite Pharmaceuticals' Form 10-K Item 1C cybersecurity disclosure describes the company's cyber risk management program aligned to the NIST Cybersecurity Framework, including annual third-party risk assessments, IPS/IDS controls, identity access management, data backups, and Audit Committee oversight. The Company states it is not aware of any cybersecurity risks that have materially affected or are reasonably likely to materially affect its business. No specific incident is disclosed.
Tracked as a single-filing incident — the only disclosure on record for this event so far.ConfirmedView incident
Source provenance
- Source URL
- https://www.sec.gov/Archives/edgar/data/1053369/000149315224025829/form10-k.htm
DisclosureLens renders the full SEC/HHS filing inline below from the originating regulator’s public record (§4.5 fair report privilege).
- Filed at
- Jul 1, 2024
- Raw hash
- 7990be34a3afe3e6c81649d504cc66e7d619d4f0090e45b501b864325376197b
Source filing
AI-assisted summary above. The structured extract on this page was generated from the document below. Inspect the source to verify or correct any field.
Reporting entity
- Name
- Elite Pharmaceuticalsnorm: elite pharmaceuticals
Victim entity
- Name
- Elite Pharmaceuticalsnorm: elite pharmaceuticals
- Industry
- Healthcarellm
Incident
- Discovered
- —
- Materiality determined
- —
- Notification sent
- —
- Affected individuals
- Not disclosed
- Data types
- —
- Attack vector
- Unknown
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.